USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: ORBIS BIOSCIENCES, INC.
City: KANSAS CITY
State: KS
Zip+4: 66013-
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,601,143.00 5

Award List:

Expanding Precision Particle Fabrication Technology for the Widespread Control of

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Maria Flynn
Award Amount: $695,173.00
Abstract:
DESCRIPTION (provided by applicant): This overall goal of this project is to develop a scalable process for fabricating oil encapsulated particles with uniform sizes and physical characteristics that contain oil as a vehicle for delivering hydrophobic drug s. Poorly water soluble active… More

Multi-day Pain Management Therapy with Novel Injectable Formulation

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Maria Flynn – 816-223-2662
Award Amount: $253,678.00
Abstract:
DESCRIPTION (provided by applicant): Our long term goal is to widespread the use of PPF technology for promoting effective production of drug-encapsulating microparticles with uniform size and physical characteristics that can be leveraged to release a specific drug at controlled rates over… More

First Generation of Controlled-Release Bacteriocins/Anti-Microbials

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency / Branch: DOD / ARMY
Principal Investigator: David W. Dumbauld, Business Development Manager – (913) 945-7796
Award Amount: $149,216.00
Abstract:
Combat ration Intermediate Moisture (IM) products use low pH and water content (aw) to discourage bacterial growth. The long-term goal of this proposal is to maintain the microbial stability of ration components over a two-year shelf life while increasing the pH and aw values for an improved… More

Precision Particle Fabrication-enabled Betamethasone-loaded Microspheres for Tran

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Nathan H. Dormer – 816-223-2662
Award Amount: $287,056.00
Abstract:
DESCRIPTION (provided by applicant): Current approaches to treat sudden sensorineural hearing loss (SSNHL) do not maintain inner ear drug concentrations within an appropriate therapeutic window for sufficient lengths of time to achieve therapeutic effect.A novel delivery system for long-term,… More

Engineering Microparticles for Taste-Masking and Controlled Release of Pediatric

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Milind Singh – 785-691-8693
Award Amount: $216,020.00
Abstract:
DESCRIPTION (provided by applicant): Pediatric drug development presents many unique challenges in the effective treatment of diseases in children, from adequate dosing information and pediatric-specific testing to palatable flavor profiles and effective delivery formats. A novel technology that… More